ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PMCB PharmaCyte Biotech Inc

2.01
0.00 (0.00%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
PharmaCyte Biotech Inc PMCB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.01 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.01
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
2/14/202415:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202409:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/15/202317:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/28/202317:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/24/202316:00EDGAR2Form 8-K - Current report
11/22/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/15/202308:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
11/09/202317:25EDGAR2Form 8-K - Current report
10/31/202309:15BWPharmaCyte Biotech Provides Corporate Update on..
9/21/202317:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
9/18/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/15/202317:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
9/11/202321:56EDGAR2Form S-3/A - Registration statement under Securities Act of..
9/07/202316:05EDGAR2Form 8-K - Current report
8/04/202316:40EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/04/202316:01EDGAR2Form 8-K - Current report
7/31/202317:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
7/31/202316:42EDGAR2Form DEF 14A - Other definitive proxy statements
7/19/202310:28EDGAR2Form PRE 14A - Other preliminary proxy statements
6/15/202309:15BWPharmaCyte Biotech Announces Final Results of Tender Offer
5/11/202308:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..

Your Recent History

Delayed Upgrade Clock